Diagnostic Approach to Inflammatory Myopathy

Initial Clinical Assessment

The American College of Physicians recommends that muscle biopsy remains the gold standard for confirming inflammatory myopathy diagnosis and is essential for differentiating inflammatory from noninflammatory causes and for subclassification 1, 2
Symmetric proximal muscle weakness developing over weeks to months is a key clinical feature to identify, manifesting as difficulty rising from a chair, climbing stairs, lifting objects overhead, and combing hair 3
Characteristic skin findings in dermatomyositis, such as heliotrope rash, Gottron's papules, photosensitive erythematous rash, and periungual telangiectasias, are important to recognize 3
The pattern of weakness in inclusion body myositis is asymmetric involvement of forearm flexors, finger flexors, and quadriceps in patients over 50 years, with insidious onset 2
Dysphagia from cricopharyngeal weakness is particularly prominent in inclusion body myositis and juvenile dermatomyositis 4, 3

The Mayo Clinic recommends that creatine kinase (CK) elevation is present in approximately 95% of inflammatory myopathies, though levels may be normal in some cases, particularly in amyopathic dermatomyositis 2, 3
CK levels in immune-mediated necrotizing myopathy often exceed 10 times normal 2
CK levels less than 12 times normal may suggest inclusion body myositis when combined with appropriate clinical features 5
A complete myositis-specific antibody panel should be ordered in all suspected cases, as approximately 80% of patients will have at least one detectable antibody that determines prognosis, extramuscular manifestations to monitor, and treatment aggressiveness required 3

Electromyography (EMG) should be performed for two critical purposes: (1) confirm myopathic process and (2) identify the optimal muscle for biopsy 4, 1, 2
Magnetic Resonance Imaging (MRI) of proximal muscle groups using T1-weighted, T2-weighted, and STIR sequences provides multiple diagnostic advantages 4, 6
Muscle biopsy is the gold standard for diagnosis, and the selection of a weak muscle demonstrated by EMG abnormalities is crucial 4, 1

Late-onset muscular dystrophy (limb-girdle dystrophy, dysferlinopathies) should be considered in patients with proximal weakness and elevated CK 4, 2
Mitochondrial myopathies can be identified by classic histopathologic findings, such as subsarcolemmal and interfibrillar mitochondrial accumulation on Gomori trichrome stain showing "ragged red fibers" 4, 2

Malignancy occurs in 25% of adult dermatomyositis patients within 0-5 years of disease onset, and age-appropriate cancer screening should be performed 6
The American College of Physicians recommends that CA-125 level may predict ovarian or primary peritoneal malignancy risk in women 6

Immediate evaluation with high-resolution chest CT and pulmonary function tests is necessary in patients with anti-synthetase antibodies or anti-MDA5 antibodies, as interstitial lung disease is common and requires close monitoring 3
Cardiac evaluation, including ECG and echocardiography, should be performed to detect arrhythmias, conduction abnormalities, and diastolic dysfunction 3

High-dose corticosteroids should be initiated concurrently with a steroid-sparing agent (methotrexate, azathioprine, or mycophenolate mofetil) in patients with non-severe disease, followed by gradual corticosteroid reduction 3
The treatment goals are to eliminate muscle inflammation, restore muscle performance, reduce morbidity, and improve quality of life 3